Treatment of bronchiolitis: state of the art

Liviana Da Dalt1, Silvia Bressan, Francesco Martinolli

  • 1Women's and Child's Health Department, Unit of Pediatric Respiratory Medicine and Allergy, Unit of Pediatric Emergency Department, University of Padova, Via Giustiniani 3, Padua,Italy.

Insights

Bronchiolitis management focuses on supportive care, with high-flow nasal cannulas and nebulized hypertonic saline improving respiratory function. While pharmacological treatments show limited benefit, prevention is key for high-risk infants.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Infectious Diseases

Background:

  • Bronchiolitis is a common cause of severe respiratory illness and hospitalization in infants and young children globally.
  • While typically mild, severe cases require hospitalization and ventilatory support.
  • Current management relies on supportive care, including oxygen therapy, hydration, and minimal handling.

Purpose of the Study:

  • To review current recommendations for bronchiolitis management and prevention.
  • To evaluate the latest literature on treatment efficacy and unanswered questions.
  • To highlight advancements in supportive care and the role of prophylaxis.

Main Methods:

  • Literature review focusing on recent studies and clinical guidelines for bronchiolitis.
  • Analysis of therapeutic interventions, including supportive care, pharmacological agents, and preventive strategies.
  • Examination of outcomes in hospitalized infants and children with severe bronchiolitis.

Main Results:

  • High-flow nasal cannulas have improved oxygen delivery.
  • Nebulized hypertonic saline demonstrates benefits for airway clearance and respiratory function.
  • Pharmacological therapies, including bronchodilators and corticosteroids, generally lack efficacy; nebulized adrenaline shows short-term benefit.

Conclusions:

  • Supportive care remains the cornerstone of bronchiolitis management.
  • Advancements in supportive care and the use of nebulized hypertonic saline offer improved outcomes.
  • Prevention strategies are crucial, particularly for high-risk populations like premature infants.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: